Home
Live Updates
GNW-Adhoc: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202 () : vimarsana.com
GNW-Adhoc: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202 ()
GNW-Adhoc: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202 () | aktiencheck.de
Related Keywords
Italy ,
Australia ,
Japan ,
Switzerland ,
United States ,
Allschwil ,
Switzerland General ,
Milan ,
Lombardia ,
American ,
Swiss ,
Markus Schlaich ,
Arthurc Corcoran ,
Andrewc Weiss ,
International Society Of Hypertension ,
European Society ,
Idorsia Pharmaceuticals Ltd ,
Head Of Investor Relations Corporate Communications ,
Swiss Exchange ,
Idorsia Ltd ,
American Heart Association ,
European Society Of Hypertension ,
Hypertension Council ,
European Society Of Cardiology ,
European Meeting ,
Uncontrolled Hypertension ,
Breaking Science ,
Management Board ,
High Blood ,
Editorial Board ,
Vice President ,
Investor Relations ,
Pharmaceuticals Ltd ,
Des Tages ,
Aktien ,
örse ,
Ktiencheck ,
Ktienkultur ,
Ktienanalysen ,
Ktienempfehlungen ,
Nalysen ,
örsennachrichten ,
Nalysten ,
Esearch ,
Eldanlage ,
Nvestment ,
örsenkurse ,
Urse ,
Harts ,
Ntraday ,
Arktberichte ,
Ewsletter ,
Ecdax ,
Dax ,
Ax ,
Ebenwerte ,
Dhoc ,
örseninformationen ,
örsenbriefe ,
örsenbrief ,
Ertpapiere ,
Mpfehlungen ,
Arrants ,
Onds ,
Ptionsscheine ,
S Rechner ,
S Vergleich ,
Ut ,
All ,
Ptionsscheinecheck ,
Euemissionen ,
Ertifikate ,
Ohstoffe ,
Nleihen ,
Evisen ,
vimarsana.com © 2020. All Rights Reserved.